Adiponectin is an abundantly circulating adipokine, orchestrating its effects through two 7-transmembrane receptors (AdipoR1 and AdipoR2). Steroidogenesis is regulated by a variety of neuropeptides and adipokines. Earlier studies have reported adipokine mediated steroid production. A key rate-limiting step in steroidogenesis is cholesterol transportation across the mitochondrial membrane by steroidogenic acute regulatory protein (StAR). Several signalling pathways regulate StAR expression. The actions of adiponectin and its role in human adrenocortical steroid biosynthesis are not fully understood. The aim of this study was to investigate the effects of adiponectin on StAR protein expression, steroidogenic genes, and cortisol production and to dissect the signalling cascades involved in the activation of StAR expression. Using qRT-PCR, Western blot analysis and ELISA, we have demonstrated that stimulation of human adrenocortical H295R cells with adiponectin results in increased cortisol secretion. This effect is accompanied by increased expression of key steroidogenic pathway genes including StAR protein expression via ERK1/2 and AMPK-dependent pathways. This has implications for our understanding of adiponectin receptor activation and peripheral steroidogenesis. Finally, our study aims to emphasise the key role of adipokines in the integration of metabolic activity and energy balance partly via the regulation of adrenal steroid production.
Introduction
Adiponectin, a recently discovered adipokine circulates abundantly in human plasma [1] . In contrast to other adipokines, adiponectin levels are inversely correlated with body mass index, percentage body fat and visceral fat; adiponectin is also significantly reduced in obesity-related disease states such as type 2 diabetes [1] . Adiponectin binds and activates two transmembrane adiponectin receptors (ADIPORs 1 and 2), which share a 66% homology in their amino acid sequence [1] .
In non-obese healthy men, serum adiponectin exhibits ultradian and circadian variations preceding or matching closely to that of cortisol, suggesting a potential feedback loop between adiponectin and cortisol secretions [2] . Interestingly, adiponectin receptors are expressed in the human adrenal gland [3] ; however the functional relevance of the ADIPORs within the adrenal gland is currently not known. Adiponectin also increases IGF-1 induced progesterone secretion in chicken ovary [4] and in rat ovarian granulosa cells [5] , suggesting that adiponectin plays a significant role in the biosynthesis of steroid hormones.
Previous studies from Bornstein's group have shown how certain adipokines regulate steroidogenesis in an adrenal cell-line [6] . Steroidogenesis involves transcription and activation of various enzymes required for this successive breakdown of cholesterol. The first key mediator of steroidogenesis is the 30 kDa steroidogenic acute regulatory (StAR) protein [7] . StAR is abundantly expressed in the steroid-producing cells, required for the transportation of cholesterol across the mitochondrial membrane (an obligatory step for steroid production) [8] . Reduction in StAR expression is the only known cause of the steroid-deficiency disease, familial lipoid adrenal hyperplasia [9] .
A number of proteins are known to stimulate or inhibit StAR expression, including ACTH, insulin, neuropeptide-Y orexin, TNFalpha, TGF-B and angiotensin [10] [11] [12] through the action of multiple signalling pathways [11, 13] . These signalling pathways include AMPK, AKT and various MAPK cascades including those mediated by ERK1/2 and p38. This variation may reflect the effects of different agonistic sites within the full length adiponectin molecule either at each of the two ADIPORs or possibly utilising even further receptor complexity.
Our current study demonstrates effects of this novel adiponectin domain on cortisol release through direct regulation of steroidogenesis in the adrenal H295R cell line. H295R cells are a widely accepted pluripotent adrenal model expressing all of the key enzymatic stages of steroidogenesis. We show evidence for expression of both ADIPOR1 and ADIPOR2 in this cell-line and show that the effects on cortisol secretion are concomitant with an AMPK, ERK1/2-mediated up-regulation of the first mediator of cholesterol metabolism, the steroidogenic acute regulatory (StAR) protein. This study increases our understanding of the agonistic properties of the adiponectin molecule and may represent a potentially important therapeutic peptide domain.
Materials and methods

Biochemical reagents and inhibitors
Insulin, transferring, selenium and Ultraserum-G (PALL Life Sciences, Cergy, France), growth supplement for H295R cells, were obtained from Sigma-Aldrich Co. Ltd. (Gillingham, Dorset, UK). Accutase required for splitting cells was obtained from TCS Cell works (Buckinghamshire, UK), and ECL plus Western blotting detection reagents were from Amersham Biosciences (Buckinghamshire, UK). Agarose was obtained from MBI Fermentas (York, UK) and Helena BioSciences Europe (Tyne & Wear, UK). Adiponectin was obtained from Phoenix Pharmaceuticals (Cat no: 028-55) (Belmont, CA). Precision Plus Protein Standard was from Bio-Rad Laboratories Ltd. (Hertfordshire, UK). Polyvinylidene difluoride (PVDF) membrane was purchased from Amersham Biosciences; all of the primers were obtained from TAGN (Newcastle, UK). Camptothecin was obtained from Calbiochem (Darmstadt, Germany). Following inhibitors were obtained from Calbiochem (Darmstadt, Germany): Compound C a potent and specific inhibitor of AMP kinase and U0126, a potent and specific inhibitor of MEK1 and MEK2.
Cell culture
H295R human adrenocortical cells were cultured in H295R complete media containing DMEM/F12 (1:1) supplemented with 2% Ultroser G (Biosepra, Villeneuve-la-Garenne, France) and ITS (Discovery Labware, Bedford, MA), in six-well plates for 24 h after reaching confluence. Medium was replaced with 2 ml fresh medium containing different cytokines and cultured for 4 and 24 h, unless otherwise indicated. At the end of the incubation period, cells were washed with ice-cold PBS and subjected to RNA or protein extraction and analysis as described below.
RT-PCR
Total RNA was extracted using the Qiagen RNeasy Mini Kit and reverse-transcribed into cDNA as previously described [14] . Adiponectin receptor(s) and steroidogenic gene expression was measured by RT-PCR, using 1 μg RNA and random primers as reverse transcription primers. A control reaction which omitted reverse transcriptase was included to check for the presence of genomic DNA. Steroidogenic gene, ADIPOR1 and ADIPOR2 expressions were amplified using a Hybrid Thermal Cycler in a 50 ml reaction medium containing 1 unit of Taq polymerase (Fermentas, York, UK), 20 pmol of each sense and antisense primer and dNTP (10 mmol/l each), using the following cycling conditions: 94°C for 1 min, then 38 cycles of 94°C for 60 s, 60°C for 45 s, and 72°C for 30 s, followed by a 10 min extension at 72°C. The sequences for the sense and anti-sense primers are shown in Table 1 . PCR products were stained with ethidium bromide and visualised by electrophoresis through 1.5% agarose gels. Sequencing of the PCR products confirmed the sequence identities.
Quantification of mRNA
The concentrations of target mRNAs were measured by reverse transcription followed by real-time PCR performed on a Roche Light Cycler system (Roche Molecular Biochemicals, Mannheim, Germany). Table 1 describes the primers used for this study. PCRs were carried out using 2.5 ml cDNA in a 5.5 ml PCR SYBR Green-1 Light Cycler 'Master Mix' (Biogene, Cambridgeshire, UK) and 1 ml sense and anti-sense primers. For studies involving steroidogenic gene expression H295R cells were incubated with adiponectin (100 nmol/l) for 4 h. A series of three dilutions for each cDNA was used to ensure linear amplification. Protocol conditions consisted of denaturation of 95 8 C for 60 s, followed by 40 cycles of 94 8 C for 1 s, 60 8 C for 8 s, and 72 8 C for 15 s, followed by melting-curve analysis. For analysis, quantitative amounts of the genes of interest were standardised against the housekeeping gene GAPDH. Negative controls for all the reactions included preparations lacking cDNA or RNA-lacking reverse transcriptase in place of the cDNA. The relative mRNA levels were expressed as a ratio using 'Delta-delta method' for comparing relative expression results between treatments in real-time PCR [15] .
Western blotting
Protein lysates were prepared by adding equal amounts of Laemmli buffer (5 M urea, 0.17 M SDS, 0.4 M dithiothreitol, and 50 mM Tris-HCl, pH 8.0) to each well, and samples were denatured by sonication and boiling. Samples were separated by SDSPAGE (10% resolving gel) and transferred to polyvinylidene difluoride (Millipore (U.K.) Limited, Watford, UK) membranes at 100 V for 1 h in a transfer buffer containing 20 mM Tris, 150 mM glycine, and 20% methanol. The PVDF membranes were incubated with primary antibody for adiponectin receptors 1 and 2 (Alpha Diagnostics Intl. Inc, San Antonio, USA) at 1:1500 dilution and β-actin (Abcam plc, Cambridge, UK) at 1:25,000 was used as control for loading made up in Tris buffered saline (TBS)-0.1% Tween (TBST), and 5% BSA overnight at 4°C. For experiments involving StAR protein the primary antibody StAR (Abcam plc, Cambridge, UK) was used at a 1:7000 dilution and β-actin (Abcam plc, Cambridge, UK) at 1:25,000 dilution in Tris buffered saline (TBS)-0.1% Tween (TBST), and 5% BSA overnight at 4°C. All the membranes were washed, incubated with a secondary anti-rabbit (ADIPOR1 and ADIPOR2), anti-rabbit (StAR), anti-mouse (β-actin, Abcam plc, Cambridge, UK) horseradish -GGCTACTCAGCATCGACCTC-3′  5′-CATCCCACTGTCACCAGATG-3′  249  Cyp11a  5′-TGGGACAGACGAGTGA-3′  5′-AGAGTTGAAATCCAACACC-3′  202  HSD3B2  5′-ACCGCCACACAGTCACATTA-3′  5′-CCCACATGCACATCTCTGTC-3′  196  Cyp21a2  5′-GAGTTCTGTGAGCGCA-3′  5′-CACGTCCACAATTTGGAT-3′  200  Cyp17  5′-GTGACCGTAACCGTCT-3′  5′-ATGAACTGATCCGGCT-3′  205  Cyp11B1  5′-TTTCTCCAGCAAGCACTGTCC-3′  5′-GGACAAAACCACAGCACCCTT-3′  102  GAPDH  5′-TGAACGGGAAGCTCACTGG-3′  5′-TCCACCACCCTGTTGCTGTA-3′  306  ADIPOR1  5′-CGGTGGAACTGGCTGAACTG-3′  5′-CCGCACCTCCTCCTCTTCTT-3′  125  ADIPOR2 5′-ACGGAGTTGTCAGCACTCAC-3′ 5′-GCCATCGTCTTGTACCTCAC-3′ 108
peroxidase-conjugated antibody (1:2000) for 1 h at room temperature, and washed for 60 min with TBST. Antibody complexes were visualised using an ECL Plus chemiluminescence detection kit (GE Healthcare UK Ltd, Buckinghamshire, UK). The densities were measured using a scanning densitometer coupled to a Scion Image scanning software (Scion Corporation, Frederick, MD, USA).
Cortisol measurements
For cortisol release experiments H295R human adrenocortical cells were cultured in H295R complete media containing DMEM/F12 (1:1) supplemented with 2% Ultroser G (Biosepra, Villeneuve-la-Garenne, France) and ITS (Discovery Labware, Bedford, MA), in six-well plates until the cells were about 80-85% confluence. Then cells were serum starved overnight in media containing DMEM/F12 (1:1) supplemented with ITS and no Ultroser G for overnight. Following overnight starvation the medium was replaced with a 2 ml fresh medium containing adiponectin (100 nmol/l) or (angiotensin 100 nmol/l) and cultured for 24 h, unless otherwise indicated. At the end of the incubation period, the supernatant was taken and snap frozen immediately and stored at − 80°C until the cortisol measurements were done. Cortisol measurements were done using the ELISA kit according to the manufacturer's instructions (ALPCO Cortisol EIA kit, Paris, France).
Cell-Titre Glo proliferation assay for analysis of adiponectin-mediated proliferation of H295R cells
H29R cells were seeded on a 96-well plate at 1 × 10 4 cells per well in quadruplet and allowed to grow for 24 h followed with serum starvation overnight. Prior to treatment with 100 nM adiponectin for 24 h at 37°C/5% CO 2 , the cells were allowed to grow in serum containing media for 24 h followed with serum starvation overnight. The Cell-Titre Glo assay (Promega, Southampton, UK) was performed according to the manufacturer's instructions. Following incubation, proliferation was quantified via bioluminescence using a luminometer. Cells stimulated with vehicle and non-seeded wells containing media alone were included as a control.
Statistical analysis
Data are shown as the means±SE from 4 different experiments. One-way ANOVA was used for multiple group comparisons followed by a Tukey's test for post hoc analysis. To analyse measurements of the intensity of immunoreactive staining, a scanning densitometer was used (Scion Image; Scion, Frederick, MD, USA). The values were considered significant if the differences in the means between the control and treated groups were greater than the P-value b0.05 (*P b 0.05; **P b 0.01; ***Pb 0.01).
Results
Adiponectin receptors are expressed in H295R cells
The expression of adiponectin receptors in human adrenocortical H295R cells was analysed by RT-PCR and Western blot analysis. Fig. 1A and B shows clear mRNA and protein ( Fig. 1C and D) expressions of both adiponectin receptors (ADIPOR1 and ADIPOR2) in the H295R adrenal cell-line, concomitant with that observed for the native human adrenal tissue [17] . Fig. 1A shows a representative ethidium bromide-stained gel showing a 125 bp PCR product for the ADIPOR1 and a 108 bp PCR product for the ADIPOR2. Bands were excised, purified and sequenced to confirm their identity. Analysis of protein by Western blotting revealed a band of 42 kDa for ADIPOR1 and 35 kDa for ADIPOR2 in both H295R cells and adipose tissue which was used as positive control. This suggests that this pluripotent cell model of adrenal steroidogenesis is also representative of an adiponectin-sensitive model of the adrenal tissue.
Adiponectin causes cortisol secretion from H295R cells
To assess the role of adiponectin on cortisol production, H295R cells were incubated with adiponectin (100 nM) for 6 h, 12 h, 24 h and 36 h with an ANG II control (100 nM; 24 h). ELISA analysis of the H295R cell media ( Fig. 2A) showed that a 24 hour stimulation of (100 nM) adiponectin maximally increased cortisol secretion to 165% ± 10% (pb 0.01). This significant functional outcome was comparable to (100 nM) angiotensin (200% ± 8%; p b 0.01), a potent standard for assessing steroidogenesis in this adrenal cell model [16] . Fig. 2C shows dose-dependent effects of adiponectin on cortisol secretion. Maximal response occurs between 10 nM and 100 nM treatments.
Effects of adiponectin on steroid regulatory gene expression in H295R cells
Quantitative determination of effects of adiponectin (100 nM) on steroid regulatory genes measured at 4 h following stimulation resulted in a significant up-regulation of StAR (165.3% ± 8; p b 0.01), CYP11A (341.2% ± 11; p b 0.001), 3βHSD (57.3% ± 4.6; p b 0.05), CYP17 (70.3% ± 10; p b 0.01) and CYP11B1 (185.6% ± 12; p b 0.01). Fig. 2B shows the changes in mRNA levels of steroidogenic regulatory enzyme genes following adiponectin treatment.
Effects of adiponectin on StAR protein expression
The genetic expression data above suggests a clear steroidogenic pathway for the observed effects of adiponectin on cortisol secretion. To confirm this at the protein level, we used Western blotting to measure the effects of adiponectin on the expression of the StAR protein following stimulation for 4 h and angiotensin (100 nM) was used as Fig. 3A shows a representative Western blot demonstrating changes in StAR protein expression following adiponectin treatment. These increases in StAR protein expression were dose-dependent (Fig. 3B) . A concentration range of 1-200 nM was used for this study showing a maximal expression at a concentration of 100 nM. Interestingly, at a higher concentration the StAR protein expression recedes towards basal levels. Fig. 3B shows a representative Western blot showing dose dependent effects of adiponectin on StAR protein expression.
Adiponectin signals through the AMPK, AKT, and ERK1/2 MAPK pathways, but not p38 in H295R cells
The downstream effects of adiponectin agonists are known to be mediated by two membrane bound receptors ADIPOR1 and ADIPOR2. Fig. 2 . Effects of adiponectin on cortisol secretion and mRNA expression of steroid biosynthesis genes in NCI-H295R cells. Cells were cultured in 6-well plates for at-least 48 h before the experiment was carried out. Cells were starved overnight in serum free media, and the following day the cells were washed and incubated in fresh serum free media with 100 nM adiponectin or 100 nM ANG for 6 h, 12 h, 24 h and 36 h. A) Time dependent effects of adiponectin on cortisol content of the medium were determined from cell culture supernatants using the EIA method and represented as percentage changes with respect to basal. B) For gene expression studies total RNA was isolated, reverse transcribed to cDNA, and used as a template for quantitative PCR using StAR, CYP11A, 3βHSD, CYP17, CYP21, CYP11B1 and GAPDH specific primers. Result were normalised against GAPDH expression and expressed as percentage change over basal. C) Dose dependent effects of adiponectin on cortisol content of the medium were determined from cell culture supernatants using the EIA method and represented as percentage changes with respect to basal. Data points are means ± SE of values from 4 different experiments. Significance was determined by one-way ANOVA followed with Tukey test for post hoc analysis against control cells (*P b 0.05; **P b 0.01). Fig. 3 . Effects of adiponectin, on StAR protein expression in H295R cells. Western blot analysis of protein extracts from H295R cells for StAR protein expression. Cells were incubated with serum free medium containing different doses of adiponectin, or control without stimulus for 4 h. A) Cells stimulated with either adiponectin of 100 nM ANG. B) Cells were stimulated with various doses of adiponectin. Following stimulation cells were washed with ice cold PBS and cell lysis was made and used for Western blotting analysis. The antibody against StAR and β-actin recognised bands with apparent molecular weights of 30 kDa, and 42 kDa respectively. Densitometric analysis of StAR protein expression was normalised to β-actin. The figure depicts the results of representative experiment, and the relative intensity (fold increase over basal) was measured by densitometry using a Scion image software from 4 independent experiments. Data points are means± SE from 4 different experiments. Significance was determined by one-way ANOVA followed with Tukey test for post hoc analysis against control cells (**P b 0.01).
These have been implicated in the activation of AMPK, AKT and several members of the MAPK family in a number of tissues and cellular models [18] [19] [20] and the N-terminal region of adiponectin has been shown to activate several pathways including ERK1/2 activation [21] and the COX2 expression [22] . Activation of some of these signalling cascades is crucial for the survival of adrenal cells. We employed Western blot analysis to test whether adiponectin-stimulation of H295R cells induced activation of AMPK, AKT, ERK1/2 and p38 MAPK. Time-dependent studies showed adiponectin activated the AMPK, AKT and ERK1/2 MAPK pathways ( Fig. 4A and B) . However there was no activation of p38 MAPK either in a time- (Fig. 4C) or concentration-dependent manner (Supplementary Fig. 1 ). 100 nM adiponectin-stimulated ERK1/2 activation peaked (5-fold) after 10 min and remained significantly higher than the basal levels even after 60 min (2.5 fold, Fig. 4A ). Activation of AMPK was slightly delayed peaking at about 20 min (2-fold) and remained significantly higher levels than basal even at 60 min.
The effects of AMPKi and ERKi on adiponectin-mediated StAR protein expression and cortisol secretion
It is known that adiponectin leads to the activation of ERK1/2 and AMPK through one or both of the ADIPORs. To assess the involvement of the above mentioned key signalling molecule involvement in adiponectin mediated StAR protein expression, we compared the relative StAR expression in response to adiponectin stimulation in the presence and absence of U0126 (MEK1/2/ERK1/2 inhibition) and compound-C (AMPK inhibition) in our experimental design. The data in Fig. 5A and B showed that both ERKi (from 4.5 ± 0.36-fold to 2.3 ± 0.20-fold over inhibitor alone) and AMPKi (from 3.4 ± 0.36-fold to 2.3 ± 0.20-fold inhibitor alone) led to a partial reduction of StAR protein expression in response to adiponectin. For cortisol secretion studies, U0126 (1 and 10 μM) alone showed a slight elevation in basal however the raise in cortisol secretion induced by U0126 alone was not statistically significant, at either concentrations (Fig. 5C ). Compound C alone (1 μM) showed no significant changes on basal cortisol levels however compound C (10 μM) induced significant reduction on basal cortisol levels (Fig. 5D) . The data from this study demonstrate that there is a significant increase in cortisol secretion in the combination treatment group of U0126 + adiponectin compared to the U0126 alone treated group (Fig. 5C ). However the combined effects were significantly lower compared to adiponectin-induced cortisol effects on basal cortisol secretion.
Further studies involving inhibition of AMPK on adiponectin induced cortisol secretion depict that compound C-inhibition of AMPK results in a significant reduction in cortisol secretion compared to adiponectininduced cortisol secretion alone (Fig. 5D) .
Adiponectin is not proliferative and has a small effect on apoptosis
Earlier studies from Ehrhart-Bornstein [23] reported a detachment of H295R cells following stimulation with adiponectin. To eliminate the possibility of induction of apoptosis in H295R by adiponectin, we studied the effects of adiponectin on proliferation and apoptosis. Stimulation of H295R cells with 100 nM adiponectin showed no significant changes in H295R cell proliferation after a 24 hour stimulation (Fig. 6A) . However DNA fragmentation assay (marker of apoptosis) assessing the effects of adiponectin on apoptosis at 24 h showed a slight increase in apoptosis of H295R cells but was not significant. Camptothecin (used as positive control for the study) showed a significant increase in apoptosis (350%) compared to the control stimulation. This data is interesting as we observed a significant, transient increase on AKT activation in response to adiponectin (Fig. 4D ) which peaked at about 10 min (2-fold) and returned to near basal by 20 min.
Discussion
Adiponectin is a recently discovered adipokine, circulating in the plasma in the range of 3 to 30 μg/ml (100 nM-1 μM) concentration in Fig. 4 . Time dependent effects of adiponectin, on ERK1/2, p38, AMPK and AKT protein phosphorylation in H295R cells. Western blot analysis of protein extracts prepared from H295R cells following stimulation with 100 nM adiponectin for various time points were analysed for ERK1/2, p38, AMPK and AKT phosphorylation. The antibody against p-ERK1/2 and ERK1/2 recognised bands with apparent molecular weights of 42 and 44 kDa. p-p38 and p38 recognised bands with apparent molecular weights of 38 kDa. P-AMPK and AMPK recognised bands with apparent molecular weights of 63 kDa. p-AKT and AKT recognised bands with apparent molecular weights of 60 kDa. Densitometric analysis of phosporylated proteins was normalised to total protein content. The figure depicts the representative experiment; the relative intensity was measured by densitometry using a Scion image software from 3 independent experiments. Data points are means ± SE, where basal was considered as one for each experiment, and fold increase over basal is shown. Significance was determined by one-way ANOVA followed with Tukey test for post hoc analysis against control cells (**P b 0.01; ***P b 0.01).
various multimeric forms. Adipokines reach the adrenal glands in an endocrine manner at concentrations sufficient to induce adrenal steroidogenesis. Also intra-adrenal adipose tissue depots in direct contact with steroid-producing adrenocortical cells could act as local sources of adipokines. This close cellular proximity forms the prerequisite for paracrine interactions and indicates a direct stimulation of steroidogenesis by adipokines [23] . Adipokines can stimulate aldosterone synthesis and secretion in an endocrine or paracrine manner with implications for hyperaldosteronism and consequently hypertension in obesity [6] . The functional importance of adiponectin receptor activation in the adrenal gland is not well studied.
In this current study, we demonstrate for the first time the expression of ADIPOR1 and ADIPOR2 mRNA and protein in human adrenocortical H295R cells. More importantly, we show stimulation of H295R cells with adiponectin results in increased expression of many steroidogenic genes, StAR protein expression, cortisol secretion and the signalling cascades involved in the regulation of StAR protein expression.
The regulation of the adrenal steroidogenic machinery is a complex process that involves the interaction of diverse hormones and multiple signalling pathways that coordinate the cooperation and interaction of transcriptional machinery as well as a number of post-transcriptional mechanisms that govern mRNA and protein expression [24] . Although ACTH and angiotensin are the major regulators of adrenal steroid production, recent evidences point out the importance of adipokines in fine tuning the regulation of steroidogenesis process [25] [26] [27] .
Our findings on investigating the effects of adiponectin stimulation in H295R cells showed a significant increase in cortisol production, together with increases in mRNA levels of key steroidogenic genes including StAR, . Cortisol secretion from H295R cells in the presence of AMPKi stimulated by 100 nM adiponectin, and angiotensinstimulated StAR expression was included as a positive control for approximate maximum expression. StAR levels were determined and quantified by Western blot exactly as described for Fig. 3 . Cortisol release from H295R cells was determined from cell culture supernatants using EIA method. Data points are means ± SE from six independent experiments. Significant difference from basal and adiponectin-stimulated expression was determined by one-way ANOVA followed with Tukey test for post hoc analysis (*, P b 0.01; ***, P b 0.001). Significance between stimulated expression ± inhibitors is indicated (#, Pb 0.05; and b, P b 0.01). These data show 100 nM adiponectin neither induced proliferative nor pro-apoptotic effects on H295R. Significance was determined by one-way ANOVA followed with Tukey test for post hoc analysis P N 0.001 compared with untreated cells.
CYP11A, 3βHSD, CYP17 and CYP11B1. It is now well documented that StAR protein expression is the first rate limiting step in the steroid biosynthesis in the adrenal gland, as StAR protein promotes the transfer of cholesterol across the mitochondrial membrane for steroid biosynthesis to take place [24, 28, 29] . Therefore we performed comprehensive analysis of effects of adiponectin and the key signalling events involved in the regulation of StAR protein expression upon stimulation with adiponectin. Stimulation of H295R cells with adiponectin resulted in a significant increase in StAR protein expression. The bell-shaped effect of dosedependent adiponectin on StAR expression was particularly interesting due to the inverse relationship between circulating adiponectin levels and obesity. Adiponectin concentrations similar to those of endogenous adiponectin found in obese people resulted in a higher StAR expression, suggesting that in obese people ADIPOR activation might play a role in activating the adrenal cells to produce more cortisol. Induction of cAMP and the cAMP-dependent signalling mechanisms is undoubtedly the principal pathway regulating StAR expression and steroid biosynthesis [30] [31] [32] . Activation of two key MAPKs (ERK1/2 and p38) and AMPK is also involved in the regulation of StAR expression and steroid production. However, the precise mechanism involved is poorly understood as a consequence of conflicting reports demonstrating stimulation, inhibition, or no effect in different steroidogenic cells [33] [34] [35] [36] .
We have shown that stimulation with adiponectin resulted in significant increases in ERK1/2 and AMPK activation in H295R cells. To elucidate the involvement of ERK1/2 and AMPK in adiponectin induced StAR expression, MEK/ERK1/2 inhibitor U0126 and the AMPK inhibitor compound-C were used. These inhibitors have been widely used for blocking relevant signalling pathways in other steroidogenic cells [11, 37] . Inhibition of both ERK1/2 and AMPK pathways resulted in partial but significant reductions in adiponectin-induced StAR expression suggesting that these two major pathways may be involved in regulating StAR expression in H295R cells. Angiotensin (used as positive control throughout the study) also showed significant increase in StAR expression, however when adiponectin was co-incubated with angiotensin there was no additive/synergistic effect observed. This data shows that adiponectin-induced cortisol secretion involves both AMPK and ERK1/2 dependent pathways. However, the combined effects of adiponectin with either inhibitors did not completely reduce the secretion of cortisol to basal levels. This may reflect that there exists a small effect of an AMPK and ERK1/2-independent mechanism for adiponectin-induced cortisol secretion.
Whilst a previous study suggested that cortisol secretion was not observed in a screen of potential mineralocorticoid-releasing factors including "adiponectin" [23] , the study does not mention which form of adiponectin was used in their studies, and they reported possible cellular necrosis with 100 nM adiponectin treatment. Our studies with the same concentration of adiponectin (100 nM) did not show any cell detachment/necrosis nor showed any significant induction of apoptosis or reduction in cell viability.
Altogether our data implicates that the ADIPORs are clearly expressed in a pluripotent H295R adrenal cell model. We show that stimulation of H295R cells with adiponectin results in increased cortisol secretion. This effect is accompanied by the increased gene expression of several key members of the steroidogenic pathway including the expression of StAR protein via ERK1/2 and AMPK-dependent pathways. This has implications for our understanding of adiponectin receptor activation and peripheral steroidogenesis. Furthermore adiponectin might play an important role in the pathophysiology of adrenal secretions in obese people.
Supplementary materials related to this article can be found online at doi:10.1016/j.bbamcr.2011.02.010.
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